Supplementary Protection Certificates (SPCs) were introduced in Europe to address a call for enhanced patent protection for pharmaceuticals that required regulatory approval to be placed on the market. The SPC provides a form of patent term extension for medicinal products based on the product that is the subject of a marketing authorisation and which is protected by a patent in force. The SPC system is distinct from patent term extension systems in other jurisdictions and presents applicants in Europe with unique challenges.
In this 30-minute webinar, we’ll run through the current state of play of SPCs in Europe, touching on recent CJEU decisions concerning the requirements for grant. We'll also discuss upcoming developments in view of the UPC and current EU Commission proposals as well as how Brexit and the Windsor Framework have affected the landscape in the UK and Europe.
We hope you’ll be able to join us!